Long-term follow-up in patients with presumptive Brugada syndrome treated with implanted defibrillators

Daniel Steven1, Kurt C Roberts-Thomson, Keiichi Inada

  • 1Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. dsteven@uke.de

Insights

Risk stratification for Brugada syndrome (BS) is challenging. For patients without prior cardiac arrest, adverse effects from implantable cardioverter-defibrillators (ICDs) may outweigh the benefits of arrhythmia protection.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Devices

Background:

  • Brugada syndrome (BS) risk stratification is difficult.
  • Implantable cardioverter-defibrillators (ICDs) offer arrhythmia protection for high-risk patients.

Purpose of the Study:

  • To evaluate the outcomes and complications of ICD implantation in patients with suspected Brugada syndrome.

Main Methods:

  • Retrospective review of 33 patients with suspected Brugada syndrome who underwent ICD implantation between 1995 and 2008.
  • Analysis of patient demographics, BS type, electrophysiology study findings, and long-term follow-up data.

Main Results:

  • The study included 30 men and 3 women, with Type I Brugada observed in 54.5% of patients.
  • During a mean follow-up of 7.9 years, only 2 patients with prior cardiac arrest received appropriate ICD shocks.
  • Adverse effects occurred in 33% of patients, including inappropriate shocks (15%) and major device-related complications (24%).

Conclusions:

  • Risk stratification for primary prevention in Brugada syndrome remains challenging.
  • The low incidence of arrhythmic events in patients without prior cardiac arrest suggests that ICD-related adverse effects may exceed the benefits.
  • Discussions regarding ICD implantation should carefully consider the risk-benefit profile for patients without a history of cardiac arrest.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...